TRILのチャート
TRILの企業情報
| symbol | TRIL |
|---|---|
| 会社名 | Trillium Therapeutics Inc （トリリウム・セラピュ―ティクス） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Major Pharmaceuticals |
| 業種 | ― 医療関連（Health Care） |
| 概要 | 事業概要 -- トリリウム・セラピュ―ティクスは、カナダの持株会社。がん免疫治療法の開発を手掛ける。腫瘍細胞が宿主免疫システムを回避するために利用する免疫調節経路を対象とした前臨床プログラムを実施。同社のプログラムは、悪性腫瘍による分子の上方制御およびヒトモノクロナ―ル抗体をブロックする抗体様融合蛋白が含まれる。 Trillium is an immuno-oncology company developing innovative therapies for the treatment of cancer. The company’s two clinical programs, TTI-621 and TTI-622, target CD47, a “don’t eat me” signal that cancer cells frequently use to evade the immune system. |
| 本社所在地 | 2488 Dunwin Drive Mississauga Ontario L5L 1J9 CAN |
| 代表者氏名 | ― |
| 代表者役職名 | ― |
| 電話番号 | ― |
| 設立年月日 | 38047 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | ―年 |
| 従業員数 | 59人 |
| url | www.trilliumtherapeutics.com |
| nasdaq_url | https://www.nasdaq.com/symbol/tril |
| adr_tso | ― |
| EBITDA | EBITDA ー |
| 終値（lastsale） | 4.31 |
| 時価総額（marketcap） | 62169586.38 |
| 時価総額 | 時価総額 ― |
| 売上高 | 売上高 -- |
| 企業価値(EV) | 企業価値(EV) ー |
| 当期純利益 | 当期純利益 -- |
| 決算概要 | 決算概要 -- |
TRILのテクニカル分析
TRILのニュース
Trillium Therapeutics (NASDAQ:TRIL) Downgraded to “Hold” at Benchmark 2021/11/17 12:20:41 Dakota Financial News
Trillium Therapeutics (NASDAQ:TRIL) (TSE:TR) was downgraded by investment analysts at Benchmark from a “buy” rating to a “hold” rating in a report released on Wednesday, The Fly reports. Other equities analysts also recently issued research reports about the company. Bloom Burton began coverage on Trillium Therapeutics in a report on Friday, October 1st. They issued […]
Trillium Therapeutics gets Canada, HSR approval for sale to Pfizer 2021/11/17 00:29:10 Seeking Alpha
Is Now The Time To Buy Trillium Therapeutics Inc. (NASDAQ: TRIL) Stock? 2021/11/16 19:00:00 Stocks Register
Trillium Therapeutics Inc. (NASDAQ:TRIL) price is hovering higher on Tuesday, November 16, jumping 2.64% above its previous close. >> 7 Top Picks for the Post-Pandemic Economy > 7 Top Picks for the Post-Pandemic Economy
Trillium Therapeutics (NASDAQ:TRIL) Sees Strong Trading Volume 2021/11/16 17:42:42 Transcript Daily
Trillium Therapeutics Inc. (NASDAQ:TRIL) (TSE:TR) shares saw unusually-strong trading volume on Tuesday . Approximately 661,216 shares were traded during trading, a decline of 62% from the previous sessions volume of 1,755,849 shares.The stock last traded at $18.39 and had previously closed at $17.97. A number of equities research analysts recently commented on TRIL shares. Craig []
Trillium Therapeutics (NASDAQ:TRIL) Downgraded to “Hold” at Benchmark 2021/11/17 12:20:41 Dakota Financial News
Trillium Therapeutics (NASDAQ:TRIL) (TSE:TR) was downgraded by investment analysts at Benchmark from a “buy” rating to a “hold” rating in a report released on Wednesday, The Fly reports. Other equities analysts also recently issued research reports about the company. Bloom Burton began coverage on Trillium Therapeutics in a report on Friday, October 1st. They issued […]
Trillium Therapeutics gets Canada, HSR approval for sale to Pfizer 2021/11/17 00:29:10 Seeking Alpha
Is Now The Time To Buy Trillium Therapeutics Inc. (NASDAQ: TRIL) Stock? 2021/11/16 19:00:00 Stocks Register
Trillium Therapeutics Inc. (NASDAQ:TRIL) price is hovering higher on Tuesday, November 16, jumping 2.64% above its previous close. >> 7 Top Picks for the Post-Pandemic Economy > 7 Top Picks for the Post-Pandemic Economy
Trillium Therapeutics (NASDAQ:TRIL) Sees Strong Trading Volume 2021/11/16 17:42:42 Transcript Daily
Trillium Therapeutics Inc. (NASDAQ:TRIL) (TSE:TR) shares saw unusually-strong trading volume on Tuesday . Approximately 661,216 shares were traded during trading, a decline of 62% from the previous sessions volume of 1,755,849 shares.The stock last traded at $18.39 and had previously closed at $17.97. A number of equities research analysts recently commented on TRIL shares. Craig []
Trillium Therapeutics (NASDAQ:TRIL) Downgraded to “Hold” at Benchmark 2021/11/17 12:20:41 Dakota Financial News
Trillium Therapeutics (NASDAQ:TRIL) (TSE:TR) was downgraded by investment analysts at Benchmark from a “buy” rating to a “hold” rating in a report released on Wednesday, The Fly reports. Other equities analysts also recently issued research reports about the company. Bloom Burton began coverage on Trillium Therapeutics in a report on Friday, October 1st. They issued […]
Trillium Therapeutics gets Canada, HSR approval for sale to Pfizer 2021/11/17 00:29:10 Seeking Alpha
Is Now The Time To Buy Trillium Therapeutics Inc. (NASDAQ: TRIL) Stock? 2021/11/16 19:00:00 Stocks Register
Trillium Therapeutics Inc. (NASDAQ:TRIL) price is hovering higher on Tuesday, November 16, jumping 2.64% above its previous close. >> 7 Top Picks for the Post-Pandemic Economy > 7 Top Picks for the Post-Pandemic Economy
Trillium Therapeutics (NASDAQ:TRIL) Sees Strong Trading Volume 2021/11/16 17:42:42 Transcript Daily
Trillium Therapeutics Inc. (NASDAQ:TRIL) (TSE:TR) shares saw unusually-strong trading volume on Tuesday . Approximately 661,216 shares were traded during trading, a decline of 62% from the previous sessions volume of 1,755,849 shares.The stock last traded at $18.39 and had previously closed at $17.97. A number of equities research analysts recently commented on TRIL shares. Craig []